Related references
Note: Only part of the references are listed.Mammalian Target of Rapamycin: Its Role in Early Neural Development and in Adult and Aged Brain Function
Carla Garza-Lombo et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2016)
Deacetylation of Nuclear LC3 Drives Autophagy Initiation under Starvation
Rui Huang et al.
MOLECULAR CELL (2015)
Sarcopenic obesity: molecular clues to a better understanding of its pathogenesis?
Robert Kob et al.
BIOGERONTOLOGY (2015)
Proteasome inhibition in skeletal muscle cells unmasks metabolic derangements in type 2 diabetes
Lubna Al-Khalili et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2014)
Autophagy-regulating TP53INP2 mediates muscle wasting and is repressed in diabetes
David Sala et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Mechanisms of muscle wasting in chronic kidney disease
Xiaonan H. Wang et al.
NATURE REVIEWS NEPHROLOGY (2014)
NUCKS Is a Positive Transcriptional Regulator of Insulin Signaling
Beiying Qiu et al.
CELL REPORTS (2014)
Increasing Muscle Mass Improves Vascular Function in Obese (db/db) Mice
Shuiqing Qiu et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)
Autophagic Degradation Contributes to Muscle Wasting in Cancer Cachexia
Fabio Penna et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Sustained Activation of mTORC1 in Skeletal Muscle Inhibits Constitutive and Starvation-Induced Autophagy and Causes a Severe, Late-Onset Myopathy
Perrine Castets et al.
CELL METABOLISM (2013)
Stat3 Activation Links a C/EBPδ to Myostatin Pathway to Stimulate Loss of Muscle Mass
Liping Zhang et al.
CELL METABOLISM (2013)
Mechanisms stimulating muscle wasting in chronic kidney disease: the roles of the ubiquitin-proteasome system and myostatin
Sandhya S. Thomas et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2013)
Muscle protein anabolism in type 2 diabetes
Maya S. Bassil et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2013)
Gene-Environment and Gene-Treatment Interactions in Type 2 Diabetes
Paul W. Franks et al.
DIABETES CARE (2013)
Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF)
Susann Fuelster et al.
EUROPEAN HEART JOURNAL (2013)
Absence of Functional Leptin Receptor Isoforms in the POUND (Leprdb/lb) Mouse Is Associated with Muscle Atrophy and Altered Myoblast Proliferation and Differentiation
Phonepasong Arounleut et al.
PLOS ONE (2013)
Effect of a Low-Protein Diet Supplemented with Ketoacids on Skeletal Muscle Atrophy and Autophagy in Rats with Type 2 Diabetic Nephropathy
Juan Huang et al.
PLOS ONE (2013)
Immune mechanisms in type 1 diabetes
Maja Wallberg et al.
TRENDS IN IMMUNOLOGY (2013)
Association between body mass index and muscularity in healthy older Japanese women and men
Hiroaki Kanehisa et al.
JOURNAL OF PHYSIOLOGICAL ANTHROPOLOGY (2013)
Hyperammonemia-mediated autophagy in skeletal muscle contributes to sarcopenia of cirrhosis
Jia Qiu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2012)
JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia
Andrea Bonetto et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2012)
Role of Muscle Mass and Muscle Quality in the Association Between Diabetes and Gait Speed
Stefano Volpato et al.
DIABETES CARE (2012)
DOR undergoes nucleo-cytoplasmic shuttling, which involves passage through the nucleolus
Caroline Mauvezin et al.
FEBS LETTERS (2012)
Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: An analysis of the PROactive study population
Wolfram Doehner et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2012)
DOR/Tp53inp2 and Tp53inp1 Constitute a Metazoan Gene Family Encoding Dual Regulators of Autophagy and Transcription
Ana Sancho et al.
PLOS ONE (2012)
Type 1 Diabetes: Current Concepts in Epidemiology, Pathophysiology, Clinical Care, and Research
Mary Joyce Gan et al.
CURRENT PROBLEMS IN PEDIATRIC AND ADOLESCENT HEALTH CARE (2012)
Genetics of Type 2 Diabetes
Emma Ahlqvist et al.
CLINICAL CHEMISTRY (2011)
Genetics of Type 1 Diabetes
Andrea K. Steck et al.
CLINICAL CHEMISTRY (2011)
Insulin resistance of amino acid and protein metabolism in type 2 diabetes
Paolo Tessari et al.
CLINICAL NUTRITION (2011)
Trends in Type 1 diabetes incidence in the UK in 0-to 14-year-olds and in 15-to 34-year-olds, 1991-2008
A. -K. Imkampe et al.
DIABETIC MEDICINE (2011)
Hyperaminoacidaemia at postprandial levels does not modulate glucose metabolism in type 2 diabetes mellitus
M. Bassil et al.
DIABETOLOGIA (2011)
Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease
Liping Zhang et al.
FASEB JOURNAL (2011)
Insulin Receptor Substrates Irs1 and Irs2 Coordinate Skeletal Muscle Growth and Metabolism via the Akt and AMPK Pathways
Yun Chau Long et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
STAT3 Activation in Skeletal Muscle Links Muscle Wasting and the Acute Phase Response in Cancer Cachexia
Andrea Bonetto et al.
PLOS ONE (2011)
Effects of type 1 diabetes mellitus on skeletal muscle: clinical observations and physiological mechanisms
Matthew P. Krause et al.
PEDIATRIC DIABETES (2011)
Reversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged Survival
Xiaolan Zhou et al.
CELL (2010)
The role of the Atg1/ULK1 complex in autophagy regulation
Noboru Mizushima
CURRENT OPINION IN CELL BIOLOGY (2010)
Proteomics Analysis of Human Skeletal Muscle Reveals Novel Abnormalities in Obesity and Type 2 Diabetes
Hyonson Hwang et al.
DIABETES (2010)
Prevalence and Determinant Factors of Sarcopenia in Patients With Type 2 Diabetes The Korean Sarcopenic Obesity Study (KSOS)
Tae Nyun Kim et al.
DIABETES CARE (2010)
The nuclear cofactor DOR regulates autophagy in mammalian and Drosophila cells
Caroline Mauvezin et al.
EMBO REPORTS (2010)
Antidiabetic Properties of Zinc-α2-Glycoprotein in ob/ob Mice
Steven T. Russell et al.
ENDOCRINOLOGY (2010)
Resting and exercise- induced IL-6 levels in children with Type 1 diabetes reflect hyperglycemic profiles during the previous 3 days
Jaime S. Rosa et al.
JOURNAL OF APPLIED PHYSIOLOGY (2010)
Distinct growth hormone receptor signaling modes regulate skeletal muscle development and insulin sensitivity in mice
Mahendra D. Mavalli et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Sedentary Behavior: Emerging Evidence for a New Health Risk
Neville Owen et al.
MAYO CLINIC PROCEEDINGS (2010)
Difficulties with physical function associated with obesity, sarcopenia, and sarcopenic-obesity in community-dwelling elderly women: the EPIDOS (EPIDemiologie de l'OSteoporose) Study
Yves Rolland et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2009)
Autophagy Is Required to Maintain Muscle Mass
Eva Masiero et al.
CELL METABOLISM (2009)
Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
Ralph A. DeFronzo et al.
DIABETES CARE (2009)
Excessive Loss of Skeletal Muscle Mass in Older Adults With Type 2 Diabetes
Seok Won Park et al.
DIABETES CARE (2009)
Inducible activation of Akt increases skeletal muscle mass and force without satellite cell activation
Bert Blaauw et al.
FASEB JOURNAL (2009)
Chronic high fat feeding attenuates load-induced hypertrophy in mice
Mitchell Sitnick et al.
JOURNAL OF PHYSIOLOGY-LONDON (2009)
The TP53INP2 Protein Is Required for Autophagy in Mammalian Cells
Jonathan Nowak et al.
MOLECULAR BIOLOGY OF THE CELL (2009)
Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes
Jeffrey C. Barrett et al.
NATURE GENETICS (2009)
Leptin Administration Favors Muscle Mass Accretion by Decreasing FoxO3a and Increasing PGC-1α in ob/ob Mice
Neira Sainz et al.
PLOS ONE (2009)
Acute hyperglycaemia induces an inflammatory response in young patients with type 1 diabetes
Daniel Gordin et al.
ANNALS OF MEDICINE (2008)
The emerging genetic architecture of type 2 diabetes
Alessandro Doria et al.
CELL METABOLISM (2008)
Skeletal Muscle-Specific Ablation of raptor, but Not of rictor, Causes Metabolic Changes and Results in Muscle Dystrophy
C. Florian Bentzinger et al.
CELL METABOLISM (2008)
Muscle atrophy, inflammation and clinical outcome in incident and prevalent dialysis patients
Juan Jesus Carrero et al.
CLINICAL NUTRITION (2008)
The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C
Valeria Facchinetti et al.
EMBO JOURNAL (2008)
IGF-1 and IGF-Binding Proteins and Bone Mass, Geometry, and Strength: Relation to Metabolic Control in Adolescent Girls With Type 1 Diabetes
Laurie J. Moyer-Mileur et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Altered kinetics of interleukin-6 and other inflammatory mediators during exercise in children with type 1 diabetes
Jaime S. Rosa et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2008)
Insulin resistance of protein metabolism in type 2 diabetes
Sandra Pereira et al.
DIABETES (2008)
FoxO3 controls autophagy in skeletal muscle in vivo
Cristina Mammucari et al.
CELL METABOLISM (2007)
FoxO3 coordinately activates protein degradation by the Autophagic/Lysosomal and proteasomal pathways in atrophying muscle cells
Jinghui Zhao et al.
CELL METABOLISM (2007)
Identification of a Novel Modulator of Thyroid Hormone Receptor-Mediated Action
Bernhard G. Baumgartner et al.
PLOS ONE (2007)
Islet gene expression and function in type 2 diabetes;: studies in the Goto-Kakizaki rat and humans
C.-G. Ostenson et al.
DIABETES OBESITY & METABOLISM (2007)
PTEN expression contributes to the regulation of muscle protein degradation in diabetes
Zhaoyong Hu et al.
DIABETES (2007)
Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes - The Health, Aging, and Body Composition Study
Seok Won Park et al.
DIABETES CARE (2007)
The physiology of obese-hyperglycemic mice [ob/ob mice]
Per Lindstrom
THESCIENTIFICWORLDJOURNAL (2007)
Autophagy and neurodegeneration: when the cleaning crew goes on strike
Marta Martinez-Vicente et al.
LANCET NEUROLOGY (2007)
Insulin resistance accelerates muscle protein degradation: Activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling
Xiaonan Wang et al.
ENDOCRINOLOGY (2006)
Chronic kidney disease causes defects in signaling through the insulin receptor sub strate/phosphatidylinositol 3-kinase/Akt pathway: Implications for muscle atrophy
James L. Bailey et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Increased muscle protein breakdown in chronic hemodialysis patients with type 2 diabetes mellitus
LB Pupim et al.
KIDNEY INTERNATIONAL (2005)
Effect of insulin with concurrent amino acid infusion on protein metabolism in rapidly growing pubertal children with type 1 diabetes
MA Godil et al.
PEDIATRIC RESEARCH (2005)
Insulin in methionine and homocysteine kinetics in healthy humans: plasma vs. intracellular models
P Tessari et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
Insulin and IGF-I stimulate the formation of the eukaryotic initiation factor 4F complex and protein synthesis in C2C12 myotubes independent of availability of external amino acids
WH Shen et al.
JOURNAL OF ENDOCRINOLOGY (2005)
Atrophy of S6K1-/- skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control
M Ohanna et al.
NATURE CELL BIOLOGY (2005)
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
DD Sarbassov et al.
SCIENCE (2005)
Insulin-like growth factor-1 and its binding proteins, IGFBP-1 and IGFBP-3, in adolescents with type-1 diabetes mellitus and microalbuminuria
A Wedrychowicz et al.
HORMONE RESEARCH (2005)
Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy
M Sandri et al.
CELL (2004)
Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated type I (slow twitch/red muscle) fiber genes, and impaired glycemic control
Y Kamei et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The high-fat diet-fed mouse -: A model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes
MS Winzell et al.
DIABETES (2004)
Sarcopenic obesity predicts Instrumental Activities of Daily Living disability in the elderly
RN Baumgartner et al.
OBESITY RESEARCH (2004)
Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression
SH Lecker et al.
FASEB JOURNAL (2004)
Control of the size of the human muscle mass
MJ Rennie et al.
ANNUAL REVIEW OF PHYSIOLOGY (2004)
The IGF-1/PI3K/Akt pathway prevents short article expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors
TN Stitt et al.
MOLECULAR CELL (2004)
IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1
JM Sacheck et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2004)
TP53INP1s and homeodomain-interacting protein kinase-2 (HIPK2) are partners in regulating p53 activity
R Tomasini et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling
K Inoki et al.
GENES & DEVELOPMENT (2003)
Increased islet volume but unchanged islet number in ob/ob mice
T Bock et al.
DIABETES (2003)
Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone developement, and impeded adipogenesis in mice lacking Akt1 and Akt2
XD Peng et al.
GENES & DEVELOPMENT (2003)
Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2
A Garami et al.
MOLECULAR CELL (2003)
Akt regulates growth by directly phosphorylating Tsc2
CJ Potter et al.
NATURE CELL BIOLOGY (2002)
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
K Inoki et al.
NATURE CELL BIOLOGY (2002)
Synthesis rate of muscle proteins, muscle functions, and amino acid kinetics in type 2 diabetes
P Halvatsiotis et al.
DIABETES (2002)
Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-Kinase/Akt pathway
BD Manning et al.
MOLECULAR CELL (2002)
Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo
SC Bodine et al.
NATURE CELL BIOLOGY (2001)
Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways
C Rommel et al.
NATURE CELL BIOLOGY (2001)
Akt1/PKBα is required for normal growth but dispensable for maintenance of glucose homeostasis in mice
H Cho et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Growth retardation and increased apoptosis in mice with homozygous disruption of the akt1 gene
WS Chen et al.
GENES & DEVELOPMENT (2001)
What do we really know about the ubiquitin-proteasome pathway in muscle atrophy?
RT Jagoe et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2001)
β-cell function and viability in the spontaneously diabetic GK rat -: Information from the GK/Par colony
B Portha et al.
DIABETES (2001)
Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle
A Musarò et al.
NATURE GENETICS (2001)
Functional and histological characteristics of skeletal muscle and the effects of leptin in the genetically obese (ob/ob) mouse
SA Warmington et al.
INTERNATIONAL JOURNAL OF OBESITY (2000)
Obesity and insulin resistance
BB Kahn et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Effects of peroxisome proliferator-activated receptor-α and -γ agonist, JTT-501, on diabetic complications in Zucker diabetic fatty rats
T Shibata et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Share Paper
